Topline
Ireland became the latest country on Sunday to halt the administration of the Covid-19 vaccine developed by AstraZenaca and Oxford University after a Norwegian regulator reported that a few recipients were developing clots blood after their doses – as a reflection of developments in other countries that have taken the same warning as the vaccine is still under clinical trials in the United States.
A medical worker fills a syringe with the Santa Caterina da Siena-Amendola vaccine AstraZeneca, which … [+]
Getty Images
Key facts
The Irish health department recommended that the administration of the AstraZeneca vaccine be suspended “temporarily” immediately on Sunday morning, citing a report by the Norwegian Medicines Agency which identified four instances of “severe hemorrhage events” in adults who received the vaccine.
In a statement, the country’s deputy chief medical officer said they had not concluded that there was “any connection” between the vaccine and the cases, but that the decision to suspend his administration had been taken. out of alert and waiting for more information.
Other countries, including Iceland, Denmark and Norway suspended their administration of the AstraZeneca vaccine last week on individual concerns about bleeding, but the World Health Organization and regional authorities have said there is no evidence that the warming was caused by the vaccines.
On Saturday, for example, the Norwegian Institute of Public Health announced that three health workers under the age of 50 were being treated for “severe cases of blood clots or cerebral hemorrhage” after receiving the AstraZeneca vaccine but said they again that the conditions were not firmly tied to the vaccine.
Meanwhile, the Piedmont region of northern Italy, which counts about 4 million residents, also stopped using the AstraZeneca vaccine on Sunday after a teacher who received the bullet died Saturday, Reuters reported, after two deaths under similar conditions were reported in nearby Sicily.
Domestically, the AstraZeneca vaccine is still undergoing phase three clinical trials and has therefore not been approved by the U.S. Food and Drug Administration, but New York Times The federal government reported Friday that it has purchased approximately 30 million doses packed at a facility in Ohio.
“An examination of our safety data of more than 10 million records has not shown any evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any particular age group, sex, batch or in any particular country. le [our] Covid-19 vaccine, “AstraZeneca said in a statement to CNN on Friday.
Quote Cruise
“More than 335 million doses of COVID-19 vaccines have been delivered worldwide to date, and no deaths have been detected as a result of COVID-19 vaccines,” WHO official Tedros Adhanom Ghebreyesus said Friday , responding to AstraZeneca ‘s statement.
Key background
The AstraZeneca Covid-19 vaccine, developed in collaboration with Oxford University, has been the subject of more research than its three approved counterparts in the US (those developed by Pfizer, Moderna and Johnson & Johnson). Clinical trials of the vaccine were suspended at home in early September for more than a month after a patient became ill in Britain, but the FDA eventually ruled that the trials were safe. start, which has been shown to be about 82% effective in preventing bulk. common Covid-19 strain. In February, the vaccine received an emergency use listing from the WHO, allowing it to start spreading in low- and middle-income countries, and in January, the vaccine was approved for use in the European Union. His fate in the US, however, is still in limbo, with no concrete plans for an emergency permit so far.
Tangent
President Joe Biden on Thursday instructed all 50 states to lower their eligibility requirements for Covid-19 vaccines by May 1, effectively opening pictures for every American adult who wants one. On Sunday, 106 million vaccines were given, according to the CDC.
Further reading
The Piedmont region of Italy has been blocking AstraZeneca’s sights for some time (Reuters)
Other countries have received approval from the Covid-19 AstraZeneca vaccine – Why not the US? (Forbes)
The U.S. is sitting on tens of millions of vaccines that the world needs (NY Times)